Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
FSD Pharma Inc.

FSD Pharma Inc. (HUGE) Stock Overview

Explore FSD Pharma Inc.’s financial performance, market position, analyst ratings, and future outlook.

HUGE●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.09
$0.01(10.10%)
U.S. Market opens in 35h 3m

FSD Pharma Inc. (HUGE)

Meyka AI Score

Z

Key Financials

Market Cap66.7K
P/E Ratio-0.19
EPS (TTM)$-16.25
ROE-0.85%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

HUGE Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of FSD Pharma Inc. (NASDAQ: HUGE) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, FSD Pharma Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HUGE on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind FSD Pharma Inc.'s NASDAQ-traded stock include a P/E ratio of -0.19 and a market capitalization of 66.7K. Combined with our AI analysis, these give both institutional and retail investors a clear view of HUGE on the NASDAQ.

Price Performance (NASDAQ: HUGE)

1-Day Change
N/A
5-Day Change
-97.93%
1-Month Change
-98.62%
3-Month Change
-99.36%
6-Month Change
-99.82%
Year-to-Date (YTD) Change
-99.85%
1-Year Change
-99.90%
3-Year Change
-99.92%
5-Year Change
-99.99%
All-Time (Max) Change
-99.99%

Contact Information

https://www.fsdpharma.com
416 854 8884
199 Bay Street, Toronto, ON, M5L 1A9

Company Facts

170 Employees
IPO DateJun 8, 2018
CountryCA

Frequently Asked Questions